Verve Therapeutics: An In Vivo Gene Editing ‘Moon Shot’ For Your Portfolio Seeking Alpha Verve Therapeutics: An In Vivo Gene Editing ‘Moon Shot’ For Your Portfolio. vivo 2 weeks
Apple slips from the top 5 in China, as domestic brands take all the top slots for the first quarter in history Fortune 2 months
Chinese companies are setting up shop anywhere but China — and the US Business Insider 4 months
Intellia’s Bet On In-Vivo Breakthroughs: A Perspective On CRISPR’s Next Frontier Seeking Alpha 7 months